Epidemiologic Study and Impact Study of a Dialysis Solution Change on the Electrocardiographic Profile of Patient

Haemodialysis Clinical Trial

— QT_DIAL  

Official title:

Epidemiologic Study and Impact Study of a Dialysis Solution Change on the Electrocardiographic Profile of Patient

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02887742
• Other study ID #: QT-DIAL (10.014)
• Status: Completed
• Phase: N/A
• First received: August 30, 2016
• Last updated: January 9, 2017
• Start date: October 2010
• Est. completion date: December 2014

Study information

• Verified date: August 2016
• Source: University Hospital, Brest
• Contact: n/a
• Is FDA regulated: No
• Health authority: France: Commission nationale de l'informatique et des libertésFrance: Comité consultatif sur le traitement de l'information en matière de recherche dans le domaine de la santé
• Study type: Observational

Clinical Trial Summary

Epidemiologic Study and Impact Study of a Dialysis Solution Change on the Electrocardiographic Profile of Patient

Recruitment information / eligibility

• Status: Completed
• Enrollment: 57
• Est. completion date: December 2014
• Est. primary completion date: December 2014
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• >18

• patient under haemodialysis treatment

• patient not objecting to study

Exclusion Criteria:

• Patient with known cardiac arrythmias

Study Design

Observational Model: Case-Crossover, Time Perspective: Cross-Sectional

Related Conditions & MeSH terms

• Haemodialysis

Locations

Country	Name	City	State
France	AUB	Brest
France	CHU Brest	Brest

Sponsors (1)

Lead Sponsor	Collaborator
University Hospital, Brest

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Description of all the cardiologic abnormalities		3 days	No